What Is PTD-DBM Peptide?
PTD-DBM is a synthetic peptide composed of a protein transduction domain, linker, and Dishevelled-binding motif. The peptide was developed as a molecular research tool based on these functional peptide components.
Research Overview Table
Chemical and Molecular Characteristics
Certificates:
Mechanism of Action Under Investigation
PTD-DBM interferes with the CXXC5–Dishevelled (Dvl) protein interaction. The peptide contains the Dishevelled-binding motif used by CXXC5 and acts as a competitor, disrupting formation of the CXXC5–Dvl complex. This interaction is involved in CXXC5-mediated negative regulation of Wnt/β-catenin signaling.
Disruption of the CXXC5–Dvl interaction with PTD-DBM was associated in published experiments with increased β-catenin signaling, including increased nuclear β-catenin and Wnt reporter activity. The studies support this interaction as the basis of PTD-DBM activity, while the complete downstream molecular mechanism remains incompletely defined.
Scientific Research Context
PTD-DBM appears in the scientific literature as an experimental peptide for studying CXXC5-related Wnt/β-catenin regulation. Investigators have used cultured cells, ex vivo tissue preparations and mouse models to examine its biological activity in areas such as cutaneous biology, osteoblast differentiation, and hair-follicle biology. The available findings come primarily from in vitro and preclinical animal models.
PTD-DBM Biology and Biological Pathways
Primary Biological Function
CXXC5 functions as a negative-feedback regulator of Wnt/β-catenin signaling. Published studies show that Wnt signaling induces CXXC5, which then limits pathway activity through its interaction with Dishevelled. This regulatory role has been examined particularly in osteoblast differentiation and cutaneous biology.
Relevant Metabolic or Signaling Pathways
The primary pathway associated with CXXC5 biology is the canonical Wnt/β-catenin pathway. Published studies examined pathway activity through β-catenin levels, nuclear localization and Wnt reporter assays. Researchers also examined this pathway in processes such as osteoblast differentiation and hair-follicle biology.
Tissue-Specific Biology
Researchers have examined CXXC5-related biology in skin, bone and hair follicles. In skin, researchers have studied CXXC5 in epidermal keratinocytes and dermal fibroblasts during cutaneous wound studies. In bone, investigators examined its role during osteoblast differentiation. In hair follicles, studies identified CXXC5 in dermal papilla cells and arrector pili muscle and examined its relationship with follicular Wnt/β-catenin activity.
Experimental Biomarkers
Reported readouts include β-catenin, alkaline phosphatase (ALP), proliferating cell nuclear antigen (PCNA), collagen I, α-SMA, endothelin-1, Fgf18 and selected Wnt reporter activity. Nuclear β-catenin and pathway reporter activity have been used to assess Wnt/β-catenin signaling, while other markers provide context for specific cellular processes examined in individual studies.
Laboratory Investigation Methods
Published PTD-DBM experiments used Western blotting, RT-PCR, immunocytochemistry, Wnt reporter assays and immunoprecipitation. Researchers used these methods to measure protein expression, gene expression, β-catenin localization, pathway activity, and protein–protein interactions. The studies also used collagen assays and cell-based functional assays to examine related cellular responses.
Experimental Models Used in Published Research
Cell-Based Models
PTD-DBM studies used human dermal fibroblasts and HaCaT keratinocytes. These cultures provide defined cellular systems, but they cannot reproduce the full organization and cell-to-cell interactions of intact skin.
Ex Vivo Tissue Models
Researchers maintained mouse vibrissa hair follicles outside the animal for PTD-DBM experiments. The isolated follicles retain their local structure, but the preparation excludes surrounding skin, circulation and other whole-body influences.
Mouse Models
The published work includes full-thickness cutaneous wound models, hair-regrowth models, and wound-induced hair-follicle neogenesis models. Their main limitation is the biological difference between mouse and human skin and hair follicles, which limits direct translation to human biology.
PTD-DBM Published Scientific Research
Cutaneous Wound Healing
The published literature has examined PTD-DBM in cutaneous wound healing, with particular attention to CXXC5 regulation in dermal fibroblasts, collagen production and wound-associated Wnt/β-catenin activity.
Hair Regrowth and Wound-Induced Hair Neogenesis
Another research area concerns hair regrowth and wound induced hair-follicle neogenesis. The work examined PTD-DBM in relation to CXXC5, Dishevelled and Wnt/β-catenin activity during these regenerative processes.
PGD₂-Associated Hair Biology
A later study examined PTD-DBM in PGD₂-associated hair loss, including the relationship among DHT, PGD₂, CXXC5 and Wnt/β-catenin signaling. The study also investigated PTD-DBM in wound-induced hair neogenesis.
Cutaneous Tumor Biology
More recent research investigated PTD-DBM in cutaneous squamous cell carcinoma models, examining cellular behavior and whether PTD-DBM altered tumor associated phenotypes or DMBA/TPA-induced skin tumor development.
Limitations of Current Research
Evidence Is Predominantly Preclinical
The direct PTD-DBM literature remains preclinical. Current publications provide experimental findings but do not establish clinical efficacy or safety. The available evidence is therefore insufficient to draw conclusions about biological effects in humans.
Human Clinical Evidence
We identified no controlled human clinical trials of PTD-DBM in the reviewed literature. Human tissue has appeared in research involving CXXC5. But this does not provide controlled clinical evidence for PTD-DBM. Human pharmacokinetic and clinical safety data remain unavailable.
Species Differences
The available evidence cannot establish that PTD-DBM produces the same biological responses across species. Differences between human and mouse skin and hair biology create uncertainty when interpreting animal research findings in relation to human biology.
Study Design Limitations
The published investigations address different biological questions and use different experimental endpoints. Some work also combines PTD-DBM with other pathway modulating agents, making it difficult to attribute every observed response specifically to PTD-DBM.
Independent Replication
Direct PTD-DBM research remains limited to a small number of publications. Independent replication by unrelated research groups would provide stronger support for the reproducibility of the reported findings and help determine whether they remain consistent across research settings.
Long-Term Evidence
Long-term information remains limited. The published studies do not adequately characterize prolonged exposure, repeated experimental use or long-term biological responses in humans. As a result, the longer-term profile of PTD-DBM remains insufficiently defined.
Analytical Documentation
HPLC can separate the principal peptide from related impurities and provide a chromatographic purity profile. LC-MS adds molecular mass information that can support identity confirmation and help detect mass-related impurities. NMR may provide complementary structural information when the peptide and sample quantity are suitable for this analysis.
A Certificate of Analysis records the analytical results assigned to a particular batch. Depending on the testing scope, it may include purity, identity, and other measured quality attributes. Using analytical data alongside a batch specific CoA helps researchers assess material consistency before an experiment and identify results that impurities or degradation may affect.
Analytical documentation verifies product identity and quality, not biological performance.
Storage and Laboratory Handling
Store PTD-DBM at 2–8°C, following the storage condition stated on the product documentation. Keep the material under the specified conditions during laboratory storage and avoid unnecessary exposure to conditions that may affect the peptide.
Handle PTD-DBM using appropriate laboratory practices and by qualified personnel. Prevent contamination during handling and keep the material appropriately contained when not in use.
Why Researchers Choose Direct SARMs?
Direct SARMs is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs, we aim to make the research supply process simple, clear, and reliable.
Frequently asked questions
Why choose us?
Direct SARMs Latvia is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs Latvia, we aim to make the research supply process simple, clear, and reliable.